BrightAccountsProduction v1.0.0 v1.0.0 2024-10-01 The company was not dormant during the period The company was trading for the entire period Unaudited Accounts FRS 105 Accounts The prinicpal activity of the company is providing scientific and technical consultancy services. 11 June 2026 1 1 NI633362 2025-09-30 NI633362 2024-09-30 NI633362 2023-09-30 NI633362 2024-10-01 2025-09-30 NI633362 2023-10-01 2024-09-30 NI633362 uk-bus:PrivateLimitedCompanyLtd 2024-10-01 2025-09-30 NI633362 uk-curr:PoundSterling 2024-10-01 2025-09-30 NI633362 uk-bus:AbridgedAccounts 2024-10-01 2025-09-30 NI633362 uk-core:CapitalReserve 2025-09-30 NI633362 uk-core:CapitalReserve 2024-09-30 NI633362 2024-10-01 2025-09-30 NI633362 uk-bus:Director1 2024-10-01 2025-09-30 NI633362 uk-bus:AuditExempt-NoAccountantsReport 2024-10-01 2025-09-30 NI633362 uk-bus:Micro-entities 2024-10-01 2025-09-30 xbrli:pure iso4217:GBP xbrli:shares
 
 
 
 
 
 
 
 
 
 
 
Pharmaco Consulting International Ltd
 
Unaudited Financial Statements
 
for the financial year ended 30 September 2025



Pharmaco Consulting International Ltd
Company Registration Number: NI633362
BALANCE SHEET
as at 30 September 2025

    2025   2024
  £   £
 
Fixed Assets 1,040   1,803
  ─────────   ─────────
Current assets 94,057   155,240
Prepayments and accrued income 1,091   -
Creditors: amounts falling due within one year (18,280)   (26,498)
  ─────────   ─────────
Net Current Assets 76,868   128,742
  ─────────   ─────────
Total Assets less Current Liabilities 77,908   130,545
Accruals and deferred income (1,800)   (2,100)
  ─────────   ─────────
Net Assets 76,108   128,445
  ═════════   ═════════
 
Capital and Reserves 76,108   128,445
  ═════════   ═════════
 
Notes to the Financial statements
   
1. General Information
 

Pharmaco Consulting International Ltd is a private company limited by shares incorporated and registered in Northern Ireland. The registered number of the company is NI633362. The registered office of the company is 55 Stream Street, Newry, Co.Down,  Northern Ireland, BT34 1HJ which is also the principal place of business of the company. The financial statements have been presented in Pound Sterling (£) which is also the functional currency of the company.

These financial statements cover the individual entity for the period ending 30th September 2025.
       
2. Employees
 
The average monthly number of employees, including director, during the financial year was as follows:
 
  2025 2024
  Number Number
 
Director 1 1
  ═════════ ═════════
       
     
     
3. For the financial year ended 30 September 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006.
 
The director confirms that the members have not required the company to obtain an audit of its financial statements for the financial year in question in accordance with section 476 of the Companies Act 2006.
 
The director acknowledges his responsibilities for ensuring that the company keeps accounting records which comply with section 386 and for preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of the financial year and of its profit and loss for the financial year in accordance with the requirements of sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.
 
These financial statements have been prepared in accordance with the provisions available to micro-entities in Part 15 of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
 
The company has taken advantage of the exemption under section 444 not to file the Director's Report, Abridged Profit and Loss Account.
 
Approved by the Director on 11 June 2026 and signed by:
 
   
________________________________  
Mr. Paul Vivian O'Hagan  
Director